Associations between the HDL-C/ApoA-I ratio and fasting glucose levels differ by glucose deciles, HDL-C/ApoA-I ratio ranges and sex
To learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG). A cross-sectional study was performed in 97,801 males and 70,773 females without known disease. The ratio of HDL-C/ApoA-I is more stable for predicting fasting g...
Saved in:
Published in | Diabetes research and clinical practice Vol. 190; p. 110021 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
01.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG).
A cross-sectional study was performed in 97,801 males and 70,773 females without known disease.
The ratio of HDL-C/ApoA-I is more stable for predicting fasting glucose levels than HDL-C or ApoA-I alone. In subjects with HDL-C/ApoA-I ≤ 0.9, HDL-C/ApoA-I ratios were negatively associated with FBG levels, with similar patterns between sexes, and the associations gradually strengthened along with the deciles of FBG increase. In subjects with HDL-C/ApoA-I > 0.9, FBG remained at relatively lower levels in both sexes, while the associations between the FBG level and the HDL-C/ApoA-I ratio turned from negative in the lowest five deciles to positive in the highest two deciles of FBG levels in males. Adjustment for known confounders only slightly attenuated the above association patterns. Subpopulations with HDL-C/ApoA-I ≤ 0.9 were distributed in the higher ranges of triglyceride (TG), non-HDL-C, total cholesterol (TC) and ApoA-I levels and lower ranges of HDL-C levels.
The HDL-C/ApoA-I ratio sorted TG, non-HDL-C, TC, ApoA-I and HDL-C levels and hence might combine more coordinating metabolic characteristics of these lipids in association with blood glucose homeostasis. |
---|---|
AbstractList | To learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG).AIMSTo learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG).A cross-sectional study was performed in 97,801 males and 70,773 females without known disease.METHODSA cross-sectional study was performed in 97,801 males and 70,773 females without known disease.The ratio of HDL-C/ApoA-I is more stable for predicting fasting glucose levels than HDL-C or ApoA-I alone. In subjects with HDL-C/ApoA-I ≤ 0.9, HDL-C/ApoA-I ratios were negatively associated with FBG levels, with similar patterns between sexes, and the associations gradually strengthened along with the deciles of FBG increase. In subjects with HDL-C/ApoA-I > 0.9, FBG remained at relatively lower levels in both sexes, while the associations between the FBG level and the HDL-C/ApoA-I ratio turned from negative in the lowest five deciles to positive in the highest two deciles of FBG levels in males. Adjustment for known confounders only slightly attenuated the above association patterns. Subpopulations with HDL-C/ApoA-I ≤ 0.9 were distributed in the higher ranges of triglyceride (TG), non-HDL-C, total cholesterol (TC) and ApoA-I levels and lower ranges of HDL-C levels.RESULTSThe ratio of HDL-C/ApoA-I is more stable for predicting fasting glucose levels than HDL-C or ApoA-I alone. In subjects with HDL-C/ApoA-I ≤ 0.9, HDL-C/ApoA-I ratios were negatively associated with FBG levels, with similar patterns between sexes, and the associations gradually strengthened along with the deciles of FBG increase. In subjects with HDL-C/ApoA-I > 0.9, FBG remained at relatively lower levels in both sexes, while the associations between the FBG level and the HDL-C/ApoA-I ratio turned from negative in the lowest five deciles to positive in the highest two deciles of FBG levels in males. Adjustment for known confounders only slightly attenuated the above association patterns. Subpopulations with HDL-C/ApoA-I ≤ 0.9 were distributed in the higher ranges of triglyceride (TG), non-HDL-C, total cholesterol (TC) and ApoA-I levels and lower ranges of HDL-C levels.The HDL-C/ApoA-I ratio sorted TG, non-HDL-C, TC, ApoA-I and HDL-C levels and hence might combine more coordinating metabolic characteristics of these lipids in association with blood glucose homeostasis.CONCLUSIONSThe HDL-C/ApoA-I ratio sorted TG, non-HDL-C, TC, ApoA-I and HDL-C levels and hence might combine more coordinating metabolic characteristics of these lipids in association with blood glucose homeostasis. To learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG). A cross-sectional study was performed in 97,801 males and 70,773 females without known disease. The ratio of HDL-C/ApoA-I is more stable for predicting fasting glucose levels than HDL-C or ApoA-I alone. In subjects with HDL-C/ApoA-I ≤ 0.9, HDL-C/ApoA-I ratios were negatively associated with FBG levels, with similar patterns between sexes, and the associations gradually strengthened along with the deciles of FBG increase. In subjects with HDL-C/ApoA-I > 0.9, FBG remained at relatively lower levels in both sexes, while the associations between the FBG level and the HDL-C/ApoA-I ratio turned from negative in the lowest five deciles to positive in the highest two deciles of FBG levels in males. Adjustment for known confounders only slightly attenuated the above association patterns. Subpopulations with HDL-C/ApoA-I ≤ 0.9 were distributed in the higher ranges of triglyceride (TG), non-HDL-C, total cholesterol (TC) and ApoA-I levels and lower ranges of HDL-C levels. The HDL-C/ApoA-I ratio sorted TG, non-HDL-C, TC, ApoA-I and HDL-C levels and hence might combine more coordinating metabolic characteristics of these lipids in association with blood glucose homeostasis. |
ArticleNumber | 110021 |
Author | Zhang, Yuetao Wang, Yue |
Author_xml | – sequence: 1 givenname: Yuetao surname: Zhang fullname: Zhang, Yuetao organization: Health Management Center, Taizhou Central Hospital (Taizhou University Hospital), No. 999 Donghai Avenue, Taizhou Economic Development Zone, Taizhou, Zhejiang Province 318000, PR China – sequence: 2 givenname: Yue surname: Wang fullname: Wang, Yue email: euy-tokyo@umin.ac.jp organization: High Dimensional Digital Medicine Division, Biovisualab, Lotus International Plaza, 7866 Humin Road, Shanghai 201102, PR China |
BookMark | eNqNkEtrGzEURkVJoU7an1DQsouMI2nehBCMmzYBQzftWuhxx5WrSI6unMTr_vGM7dBFKCQrCfSdAzrH5CjEAIR85mzKGW_OVlPrlE6AU8GEmHLOmODvyIR3rSg6IdojMhl33f7-gRwjrhhjTVnVE_J3hhiNU9nFgFRDfgAINP8Gev11UczPZus4K25o2g2oCpYOCrMLS7r0GxMRqId78EitGwZIVG__PVgwzgOe_k-UVFgC7n0Ijx_J-0F5hE_P5wn59e3q5_y6WPz4fjOfLQpT9k0uWlMxq1veaKP7ahBg6q7tmrLtRc2qqmTQic5qW2kt7NAPtR0_KTRXthesrJvyhHw5eNcp3m0As7x1aMB7FSBuUIqmr_qm7NtynNaHqUkRMcEg18ndqrSVnMlddLmSz9HlLro8RB-58xeccXkfNyfl_Kv05YEei8K9gyTROAgGrEtgsrTRvWq4eGEw3gVnlP8D2zfwT3V8tlg |
CitedBy_id | crossref_primary_10_1016_j_numecd_2022_09_004 crossref_primary_10_1186_s12944_024_02281_z |
Cites_doi | 10.1001/archinte.167.10.1068 10.2337/diacare.28.8.2013 10.2337/db14-1603 10.1373/clinchem.2012.196949 10.1016/j.cocis.2005.11.006 10.1016/S0022-2275(20)41338-0 10.2337/dc14-0645 10.1038/s41569-021-00538-z 10.1056/NEJMoa1300955 10.3390/cells10040850 10.1210/jc.2013-1680 10.14797/mdcj-15-1-55 10.1007/s00125-020-05320-3 10.2337/db09-1114 10.1056/NEJMoa1706444 10.1097/MED.0000000000000139 10.1038/nsmb.2028 10.1161/CIRCULATIONAHA.108.843219 10.1093/cvr/cvu143 10.1530/EJE-14-0195 10.2337/diabetes.52.2.453 10.1001/jamacardio.2018.2112 10.1001/jamacardio.2018.2121 10.1161/CIRCRESAHA.119.312617 10.1038/nrendo.2011.235 10.1210/jc.2019-01080 10.1016/S0140-6736(12)60312-2 10.2337/dc21-Sint |
ContentType | Journal Article |
Copyright | 2022 Elsevier B.V. Copyright © 2022 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2022 Elsevier B.V. – notice: Copyright © 2022 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION 7X8 |
DOI | 10.1016/j.diabres.2022.110021 |
DatabaseName | CrossRef MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1872-8227 |
ExternalDocumentID | 10_1016_j_diabres_2022_110021 S016882272200835X |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29F 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABGSF ABJNI ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX ADVLN AEBSH AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HZ~ IHE J1W KOM LZ1 M29 M41 MO0 N9A O-L O9- OAUVE OB0 ON- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SEL SES SEW SPCBC SSH SSU SSZ T5K WUQ X7M Z5R ZGI ~G- AACTN AAIAV ABLVK ABYKQ AFKWA AHPSJ AJBFU AJOXV AMFUW DOVZS EFLBG LCYCR RIG ZA5 AAYXX AFCTW AGRNS CITATION 7X8 |
ID | FETCH-LOGICAL-c396t-7c40db716bcb94f2ec587863792504430e828dbd4bb2df9f5d0062b1ad9203563 |
IEDL.DBID | .~1 |
ISSN | 0168-8227 1872-8227 |
IngestDate | Fri Jul 11 06:47:14 EDT 2025 Tue Jul 01 01:02:54 EDT 2025 Thu Apr 24 22:51:09 EDT 2025 Fri Feb 23 02:40:14 EST 2024 Tue Aug 26 16:32:18 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Quantile regression HDL-C/ApoA-I ratio Fasting glucose |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c396t-7c40db716bcb94f2ec587863792504430e828dbd4bb2df9f5d0062b1ad9203563 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PQID | 2694963973 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2694963973 crossref_primary_10_1016_j_diabres_2022_110021 crossref_citationtrail_10_1016_j_diabres_2022_110021 elsevier_sciencedirect_doi_10_1016_j_diabres_2022_110021 elsevier_clinicalkey_doi_10_1016_j_diabres_2022_110021 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | August 2022 2022-08-00 20220801 |
PublicationDateYYYYMMDD | 2022-08-01 |
PublicationDate_xml | – month: 08 year: 2022 text: August 2022 |
PublicationDecade | 2020 |
PublicationTitle | Diabetes research and clinical practice |
PublicationYear | 2022 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Schmidt, Duncan, Bang, Pankow, Ballantyne, Golden (b0055) 2005; 28 Lee, Kim, Park (b0050) 2019; 104 German, Smilowitz, Zivkovic (b0120) 2006; 11 Davidson, Shah (b0095) 2019; 15 1217-27. Garvey, Kwon, Zheng, Shaughnessy, Wallace, Hutto (b0130) 2003; 52 Cochran, Ong, Manandhar, Rye (b0045) 2021; 10 Huang, Silva, Jerome, Kontush, Chapman, Curtiss (b0010) 2011; 18 203-12. Drew, Rye, Duffy, Barter, Kingwell (b0005) 2012; 8 Hwang, Ahn, Park, Park (b0080) 2014; 171 Kunitake, Mendel, Hennessy (b0110) 1992; 33 Oda (b0090) 2015; 22 Mora, Otvos, Rosenson, Pradhan, Buring, Ridker (b0135) 2010; 59 Mackey, Mora, Bertoni, Wassel, Carnethon, Sibley (b0140) 2015; 38 Mazer, Giulianini, Paynter, Jordan, Mora (b0105) 2013; 59 HPS2-THRIVE Collaborative Group, Landray MJ, Haynes R, et al. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014 HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, et al. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med 2017 Introduction: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021 Ouimet, Barrett, Fisher (b0020) 2019; 124 Feingold KR. Introduction to Lipids and Lipoproteins. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from Grundy, Stone, Bailey (b0150) 2019; 139 Pownall, Rosales, Gillard, Gotto (b0015) 2021; 18 Voight, Peloso, Orho-Melander, Frikke-Schmidt, Barbalic, Jensen (b0040) 2012; 380 Drew, Duffy, Formosa, Natoli, Henstridge, Penfold (b0070) 2009; 119 Nicholls, Andrews, Kastelein, Merkely, Nissen, Ray (b0035) 2018; 3 Abbasi, Corpeleijn, Gansevoort (b0065) 2013; 98 von Eckardstein, Widmann (b0100) 2014; 103 . S1–S2. Haase, Tybjærg-Hansen, Nordestgaard, Frikke-Schmidt (b0085) 2015; 64 Ahmed, Byrne, Pazderska, Segurado, Guo, Gunness (b0125) 2021; 64 Nicholls, Puri, Ballantyne, Jukema, Kastelein, Koenig (b0030) 2018; 3 Wilson, Meigs, Sullivan, Fox, Nathan, D'Agostino (b0060) 2007; 167 Mora (10.1016/j.diabres.2022.110021_b0135) 2010; 59 Huang (10.1016/j.diabres.2022.110021_b0010) 2011; 18 Voight (10.1016/j.diabres.2022.110021_b0040) 2012; 380 Schmidt (10.1016/j.diabres.2022.110021_b0055) 2005; 28 10.1016/j.diabres.2022.110021_b0075 Mazer (10.1016/j.diabres.2022.110021_b0105) 2013; 59 German (10.1016/j.diabres.2022.110021_b0120) 2006; 11 Drew (10.1016/j.diabres.2022.110021_b0005) 2012; 8 Abbasi (10.1016/j.diabres.2022.110021_b0065) 2013; 98 Hwang (10.1016/j.diabres.2022.110021_b0080) 2014; 171 Pownall (10.1016/j.diabres.2022.110021_b0015) 2021; 18 von Eckardstein (10.1016/j.diabres.2022.110021_b0100) 2014; 103 Nicholls (10.1016/j.diabres.2022.110021_b0030) 2018; 3 10.1016/j.diabres.2022.110021_b0025 10.1016/j.diabres.2022.110021_b0145 Drew (10.1016/j.diabres.2022.110021_b0070) 2009; 119 Wilson (10.1016/j.diabres.2022.110021_b0060) 2007; 167 Nicholls (10.1016/j.diabres.2022.110021_b0035) 2018; 3 Garvey (10.1016/j.diabres.2022.110021_b0130) 2003; 52 Haase (10.1016/j.diabres.2022.110021_b0085) 2015; 64 Mackey (10.1016/j.diabres.2022.110021_b0140) 2015; 38 Ouimet (10.1016/j.diabres.2022.110021_b0020) 2019; 124 Kunitake (10.1016/j.diabres.2022.110021_b0110) 1992; 33 Cochran (10.1016/j.diabres.2022.110021_b0045) 2021; 10 Davidson (10.1016/j.diabres.2022.110021_b0095) 2019; 15 Lee (10.1016/j.diabres.2022.110021_b0050) 2019; 104 Grundy (10.1016/j.diabres.2022.110021_b0150) 2019; 139 10.1016/j.diabres.2022.110021_b0115 Oda (10.1016/j.diabres.2022.110021_b0090) 2015; 22 Ahmed (10.1016/j.diabres.2022.110021_b0125) 2021; 64 |
References_xml | – reference: S1–S2. – volume: 18 start-page: 416 year: 2011 end-page: 422 ident: b0010 article-title: Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma publication-title: Nat Struct Mol Biol – volume: 33 start-page: 1807 year: 1992 end-page: 1816 ident: b0110 article-title: Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities publication-title: J Lipid Res – volume: 59 start-page: 1153 year: 2010 end-page: 1160 ident: b0135 article-title: Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women publication-title: Diabetes – volume: 18 start-page: 712 year: 2021 end-page: 723 ident: b0015 article-title: High-density lipoproteins, reverse cholesterol transport and atherogenesis publication-title: Nat Rev Cardiol – volume: 22 start-page: 133 year: 2015 end-page: 141 ident: b0090 article-title: High-density lipoprotein cholesterol: origins and the path ahead publication-title: Curr Opin Endocrinol Diabetes Obes – volume: 15 start-page: 55 year: 2019 end-page: 61 ident: b0095 article-title: High-Density Lipoprotein Subspecies in Health and Human Disease: Focus on Type 2 Diabetes publication-title: Methodist Debakey Cardiovasc J – volume: 11 start-page: 171 year: 2006 end-page: 183 ident: b0120 article-title: Lipoproteins: When size really matters publication-title: Curr Opin Colloid Interface Sci – reference: 203-12. – volume: 167 start-page: 1068 year: 2007 end-page: 1074 ident: b0060 article-title: Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study publication-title: Arch Intern Med – volume: 124 start-page: 1505 year: 2019 end-page: 1518 ident: b0020 article-title: HDL and Reverse Cholesterol Transport publication-title: Circ Res – volume: 8 start-page: 237 year: 2012 end-page: 245 ident: b0005 article-title: The emerging role of HDL in glucose metabolism publication-title: Nat Rev Endocrinol – volume: 104 start-page: 5633 year: 2019 end-page: 5641 ident: b0050 article-title: HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study publication-title: J Clin Endocrinol Metab – volume: 38 start-page: 628 year: 2015 end-page: 636 ident: b0140 article-title: Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis publication-title: Diabetes Care – volume: 10 start-page: 850 year: 2021 ident: b0045 article-title: High Density Lipoproteins and Diabetes publication-title: Cells – volume: 103 start-page: 384 year: 2014 end-page: 394 ident: b0100 article-title: High-density lipoprotein, beta cells, and diabetes publication-title: Cardiovasc Res – volume: 64 start-page: 3328 year: 2015 end-page: 3333 ident: b0085 article-title: HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study publication-title: Diabetes – volume: 3 start-page: 806 year: 2018 ident: b0030 article-title: Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial publication-title: JAMA Cardiol – reference: 1217-27. – volume: 119 start-page: 2103 year: 2009 end-page: 2111 ident: b0070 article-title: High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus publication-title: Circulation – volume: 59 start-page: 949 year: 2013 end-page: 958 ident: b0105 article-title: A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study publication-title: Clin Chem – reference: HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, et al. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med 2017; – volume: 3 start-page: 815 year: 2018 ident: b0035 article-title: Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial publication-title: JAMA Cardiol – volume: 64 start-page: 656 year: 2021 end-page: 667 ident: b0125 article-title: HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study publication-title: Diabetologia – reference: Feingold KR. Introduction to Lipids and Lipoproteins. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: – volume: 28 start-page: 2013 year: 2005 end-page: 2018 ident: b0055 article-title: Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study publication-title: Diabetes Care – reference: . – reference: HPS2-THRIVE Collaborative Group, Landray MJ, Haynes R, et al. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014; – volume: 171 start-page: 137 year: 2014 end-page: 142 ident: b0080 article-title: Association of HDL-C and apolipoprotein A-I with the risk of type 2 diabetes in subjects with impaired fasting glucose publication-title: Eur J Endocrinol – volume: 52 start-page: 453 year: 2003 end-page: 462 ident: b0130 article-title: Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance publication-title: Diabetes – volume: 98 start-page: E1352 year: 2013 end-page: E1359 ident: b0065 article-title: Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study publication-title: J Clin Endocrinol Metab – volume: 380 start-page: 572 year: 2012 end-page: 580 ident: b0040 article-title: Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study publication-title: Lancet – volume: 139 start-page: e1082 year: 2019 end-page: e1143 ident: b0150 article-title: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines publication-title: Circulation – reference: Introduction: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021; – volume: 167 start-page: 1068 year: 2007 ident: 10.1016/j.diabres.2022.110021_b0060 article-title: Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study publication-title: Arch Intern Med doi: 10.1001/archinte.167.10.1068 – volume: 28 start-page: 2013 issue: 8 year: 2005 ident: 10.1016/j.diabres.2022.110021_b0055 article-title: Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study publication-title: Diabetes Care doi: 10.2337/diacare.28.8.2013 – volume: 64 start-page: 3328 year: 2015 ident: 10.1016/j.diabres.2022.110021_b0085 article-title: HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study publication-title: Diabetes doi: 10.2337/db14-1603 – volume: 59 start-page: 949 year: 2013 ident: 10.1016/j.diabres.2022.110021_b0105 article-title: A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study publication-title: Clin Chem doi: 10.1373/clinchem.2012.196949 – volume: 11 start-page: 171 issue: 2-3 year: 2006 ident: 10.1016/j.diabres.2022.110021_b0120 article-title: Lipoproteins: When size really matters publication-title: Curr Opin Colloid Interface Sci doi: 10.1016/j.cocis.2005.11.006 – volume: 33 start-page: 1807 issue: 12 year: 1992 ident: 10.1016/j.diabres.2022.110021_b0110 article-title: Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)41338-0 – volume: 38 start-page: 628 issue: 4 year: 2015 ident: 10.1016/j.diabres.2022.110021_b0140 article-title: Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis publication-title: Diabetes Care doi: 10.2337/dc14-0645 – volume: 18 start-page: 712 issue: 10 year: 2021 ident: 10.1016/j.diabres.2022.110021_b0015 article-title: High-density lipoproteins, reverse cholesterol transport and atherogenesis publication-title: Nat Rev Cardiol doi: 10.1038/s41569-021-00538-z – ident: 10.1016/j.diabres.2022.110021_b0025 doi: 10.1056/NEJMoa1300955 – volume: 10 start-page: 850 issue: 4 year: 2021 ident: 10.1016/j.diabres.2022.110021_b0045 article-title: High Density Lipoproteins and Diabetes publication-title: Cells doi: 10.3390/cells10040850 – volume: 98 start-page: E1352 year: 2013 ident: 10.1016/j.diabres.2022.110021_b0065 article-title: Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-1680 – volume: 15 start-page: 55 year: 2019 ident: 10.1016/j.diabres.2022.110021_b0095 article-title: High-Density Lipoprotein Subspecies in Health and Human Disease: Focus on Type 2 Diabetes publication-title: Methodist Debakey Cardiovasc J doi: 10.14797/mdcj-15-1-55 – volume: 64 start-page: 656 issue: 3 year: 2021 ident: 10.1016/j.diabres.2022.110021_b0125 article-title: HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study publication-title: Diabetologia doi: 10.1007/s00125-020-05320-3 – volume: 59 start-page: 1153 year: 2010 ident: 10.1016/j.diabres.2022.110021_b0135 article-title: Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women publication-title: Diabetes doi: 10.2337/db09-1114 – ident: 10.1016/j.diabres.2022.110021_b0115 – ident: 10.1016/j.diabres.2022.110021_b0075 doi: 10.1056/NEJMoa1706444 – volume: 22 start-page: 133 year: 2015 ident: 10.1016/j.diabres.2022.110021_b0090 article-title: High-density lipoprotein cholesterol: origins and the path ahead publication-title: Curr Opin Endocrinol Diabetes Obes doi: 10.1097/MED.0000000000000139 – volume: 18 start-page: 416 issue: 4 year: 2011 ident: 10.1016/j.diabres.2022.110021_b0010 article-title: Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma publication-title: Nat Struct Mol Biol doi: 10.1038/nsmb.2028 – volume: 119 start-page: 2103 issue: 15 year: 2009 ident: 10.1016/j.diabres.2022.110021_b0070 article-title: High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.843219 – volume: 103 start-page: 384 issue: 3 year: 2014 ident: 10.1016/j.diabres.2022.110021_b0100 article-title: High-density lipoprotein, beta cells, and diabetes publication-title: Cardiovasc Res doi: 10.1093/cvr/cvu143 – volume: 171 start-page: 137 year: 2014 ident: 10.1016/j.diabres.2022.110021_b0080 article-title: Association of HDL-C and apolipoprotein A-I with the risk of type 2 diabetes in subjects with impaired fasting glucose publication-title: Eur J Endocrinol doi: 10.1530/EJE-14-0195 – volume: 52 start-page: 453 issue: 2 year: 2003 ident: 10.1016/j.diabres.2022.110021_b0130 article-title: Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance publication-title: Diabetes doi: 10.2337/diabetes.52.2.453 – volume: 3 start-page: 806 issue: 9 year: 2018 ident: 10.1016/j.diabres.2022.110021_b0030 article-title: Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2018.2112 – volume: 3 start-page: 815 issue: 9 year: 2018 ident: 10.1016/j.diabres.2022.110021_b0035 article-title: Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2018.2121 – volume: 124 start-page: 1505 issue: 10 year: 2019 ident: 10.1016/j.diabres.2022.110021_b0020 article-title: HDL and Reverse Cholesterol Transport publication-title: Circ Res doi: 10.1161/CIRCRESAHA.119.312617 – volume: 8 start-page: 237 issue: 4 year: 2012 ident: 10.1016/j.diabres.2022.110021_b0005 article-title: The emerging role of HDL in glucose metabolism publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2011.235 – volume: 104 start-page: 5633 year: 2019 ident: 10.1016/j.diabres.2022.110021_b0050 article-title: HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2019-01080 – volume: 380 start-page: 572 issue: 9841 year: 2012 ident: 10.1016/j.diabres.2022.110021_b0040 article-title: Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study publication-title: Lancet doi: 10.1016/S0140-6736(12)60312-2 – volume: 139 start-page: e1082 year: 2019 ident: 10.1016/j.diabres.2022.110021_b0150 article-title: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines publication-title: Circulation – ident: 10.1016/j.diabres.2022.110021_b0145 doi: 10.2337/dc21-Sint |
SSID | ssj0006345 |
Score | 2.3786194 |
Snippet | To learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG).
A cross-sectional... To learn how high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (ApoA-I) are associated with fasting blood glucose (FBG).AIMSTo learn how... |
SourceID | proquest crossref elsevier |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 110021 |
SubjectTerms | Fasting glucose HDL-C/ApoA-I ratio Quantile regression |
Title | Associations between the HDL-C/ApoA-I ratio and fasting glucose levels differ by glucose deciles, HDL-C/ApoA-I ratio ranges and sex |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S016882272200835X https://dx.doi.org/10.1016/j.diabres.2022.110021 https://www.proquest.com/docview/2694963973 |
Volume | 190 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA6iIF7EJ76J4NFsa5Im6XFZlfV5UWFvpXkUFOkudgW9ePGPm2nT9YGieGybCSUz-TKTfDNBaC9htNCGMyLTQhCu_JzTPNHE2sRyGwtjHOx3XFyK_g0_HSSDKdRrc2GAVhmwv8H0Gq3DmyiMZjS6vY2uvLPi3UMqKa39iAFksHMJVt55ead5CMYbGqNQBFq_Z_FEdx3Y3_RRrQ8TKQVCfEwPflqfviB1vfwcL6D54DfibvNri2jKlUto9iKcjC-j1w_jXOHAvsLeu8P9w3PSi7qjYZec4FrfOC8tLvIKGM84cNbxPbCHKtxcmIL18-SDdcYjR7X_XUcPkJpQ1f1V7mkF3RwfXff6JFywQAxLxZhIw2OrfcSkjU55QZ1JlFSCyRQKm3EWOx-PWW251tQWaZFYSLnUB7lNacwSwVbRdDks3RrCirECaslLaTws5LnKmZGKQ7lDI4VV64i3w5qZUH0cLsG4z1qa2V0WtJGBNrJGG-uoMxEbNeU3fhMQrc6yNrfUo2HmF4jfBNVE8JMB_kV0tzWOzE9OOHHJSzd89I1EylM4OmUb_-9-E83BU8M63ELT44dHt-09obHeqU19B810T876l2_ycAX1 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELZgK0EvVVtAPFpqpB7rTbAd2zmutkVLu8ulIO3Nih-RQCi7IotULlz443gSZ7dURVS9xh4r8tifZ-xvZhD6nDFaGssZkXkpCFdhzxmeGeJc5rhLhbUe7jsmZ2J0wb9Ps-kaGnaxMECrjNjfYnqD1vFLEmczmV9eJj-DsRLMQyopbeyI6Tp6xcP2hTIG_fsVz0Mw3vIYhSLQfRXGk1z14YIzuLXBT6QUGPEpPX7ugPoDqpvz5-QtehMNRzxo_-0dWvPVe7QxiU_jW-jht4mucaRf4WDe4dHXMRkmg_lsQE5xo3BcVA6XRQ2UZxxJ6_ga6EM1biumYHO3bHDeBuiov_xtoBuITaib8Wr_axtdnHw7H45IrLBALMvFgkjLU2eCy2SsyXlJvc2UVILJHDKbcZb64JA547gx1JV5mTmIuTTHhctpyjLBdlCvmlV-F2HFWAnJ5KW0AReKQhXMSsUh36GVwqk9xLtp1TamH4cqGNe645ld6agNDdrQrTb2UH8pNm_zb7wkIDqd6S64NMChDifES4JqKfhkBf6L6FG3OHTYnfDkUlR-dhs6iZzn8HbK9v9_-E9oc3Q-Gevx6dmPA_QaWloK4gfUW9zc-o_BLFqYw2bZPwLZrAeD |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Associations+between+the+HDL-C%2FApoA-I+ratio+and+fasting+glucose+levels+differ+by+glucose+deciles%2C+HDL-C%2FApoA-I+ratio+ranges+and+sex&rft.jtitle=Diabetes+research+and+clinical+practice&rft.au=Zhang%2C+Yuetao&rft.au=Wang%2C+Yue&rft.date=2022-08-01&rft.pub=Elsevier+B.V&rft.issn=0168-8227&rft.eissn=1872-8227&rft.volume=190&rft_id=info:doi/10.1016%2Fj.diabres.2022.110021&rft.externalDocID=S016882272200835X |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-8227&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-8227&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-8227&client=summon |